1. H. Dahlheim, I. C. M. Jacob, J. Pschorr, and J. Rosenthal, The renin angiotensin system in the extrarenal vascular walls: An approach to studies in humans, in: “Hormones in Normal and Abnormal Human Tissues,” Vol. 3, K. Fotherby and S. B. Pal, eds., Walter de Gruyter & Co., Berlin, New York (1983).
2. Z. P. Horowitz, Pharmacology and mechanism of action of inhibitors of the renin angiotensin system, in: “Drug Development and Evaluation, Vol 4: Pharmacology and Use of Angiotensin I Converting Enzyme Inhibitors,” F. Gross and R. K. Liedtke, eds., Fischer-Verlag, Stuttgart, New York (1980).
3. J. Rosenthal, B. Pfeifle, M. L. Michailov, J. Pschorr, I. C. M. Jacob, and H. Dahlheim, Investigations on components of the renin angiotensin system in rat vascular tissue, Hypertension, 6: 383–390 (1984).
4. W. Burghardt, H. Schweisfurth,, and H. Dahlheim, Juxtaglomerular angiotensin II formation, Kidney Int., 22 (Suppl. 12): S49–S54 (1982).
5. H. Dahlheim, K. Petschauer, and K. Thurau, Anreicherung und Charakterisierung der erythrocytenangiotensinase, Pflügers Arch, 305: 105–117 (1969).